IQVIA Holdings Inc (IQV)
Industry Diagnostics & Research
This stock can be held in an Investment ISA and an Investment Account
Sell
$145.00
Buy
$171.49
$2.38 (+1.58%)
Prices updated at 02 May 2025, 23:10 EDT
| Prices minimum 15 mins delay
Prices in USD
IQVIA Holdings Inc is an information and technology-enabled healthcare service provider to the pharmaceutical services, biotechnology, and healthcare industries. The Commercial Solutions and Research and Development Solutions generate maximum revenue.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
---|---|
2024 | 34.89 |
2023 | 34.96 |
2022 | 34.89 |
2021 | 33.45 |
2020 | 33.97 |
2019 | 34.16 |
2018 | 35.21 |
2017 | 35.05 |
2016 | 30.33 |
Valuation data table
Year | Price / Sales |
---|---|
2025 | 1.80 |
2024 | 2.37 |
2023 | 2.92 |
2022 | 2.75 |
2021 | 4.07 |
2020 | 3.20 |
2019 | 2.86 |
2018 | 2.38 |
2017 | 2.37 |
2016 | 1.53 |
2015 | 1.55 |
Price/Forward earnings (YTD)
12.69
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
---|---|
2024 | 5.13 |
2023 | 5.22 |
2022 | 4.36 |
2021 | 3.92 |
2020 | 1.17 |
2019 | 0.83 |
2018 | 1.14 |
2017 | 5.80 |
2016 | 0.57 |
Debt profile data table
Year | Financial leverage |
---|---|
2024 | 4.43 |
2023 | 4.37 |
2022 | 4.39 |
2021 | 4.09 |
2020 | 4.09 |
2019 | 3.87 |
2018 | 3.36 |
2017 | 2.86 |
2016 | 2.46 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.